Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S. Arunachalam, Bali Pulendran|Nature|2021Cited by 563
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Scott D. Boyd, Sandra C. A. Nielsen et al.|Cell|2022Cited by 495
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccineChunfeng Li, Bali Pulendran, Audrey Lee et al.|Nature Immunology|2022Cited by 480
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersPrabhu S. Arunachalam, Bali Pulendran|Nature Medicine|2020Cited by 168
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Taia T. Wang, Stephanie L. Gaw et al.|Science Translational Medicine|2022Cited by 137